Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Avastin® (Bevacizumab) in Combination With Chemotherapy for Treatment of First-line Metastatic Colorectal Adenocarcinoma

NCT01506167 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01506167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01506167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Avastin® (Bevacizumab) in Combination With Chemotherapy for Treatment of First-line Metastatic Colorectal Adenocarcinoma
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
July 6, 2012
Completion date
March 10, 2017
Enrollment
719 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer